April 5, 2021 by Ankit Nigam 0 ASCO and ESMO Abstracts 2020 ASCO Abstracts ASCO: Lisocabtagene maraleucel (liso-cel) Abstract No : 8040 Indication : Non-Hodgkin's Lymphoma (aggressive) Intervention : Lisocabtagene maraleucel Company : Juno Therapeutics, a Bristol-Myers...
